In Madagascar, the people living with hiv antiretroviral therapy coverage currently stands at 18%, reflecting an increase of 4% (28.6%) compared to 2021.
People living with HIV antiretroviral therapy coverage in Madagascar
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
Similar regions to Madagascar
More indicators for Madagascar
Male unintentional poisoning
1.5
-0.2
(2021)
Female wasting in children
6.4%
+1.1%
(2021)
Female prevalence of HIV
0.2%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar18
-intl dollar0
(2022)
Birth registration
73.8%
-4.8%
(2021)
Contraceptive modern method prevalence
42.7%
+2.3%
(2021)
Madagascar Antiretroviral therapy coverage between 2000 and 2022
Period | Value | Change |
---|---|---|
2022 | 18% | +4% |
2021 | 14% | +4% |
2020 | 10% | 0% |
2019 | 10% | +3% |
2018 | 7% | +2% |
2017 | 5% | +1% |
2016 | 4% | 0% |
2015 | 4% | +1% |
2014 | 3% | +1% |
2013 | 2% | 0% |
2012 | 2% | 0% |
2011 | 2% | 0% |
2010 | 2% | +1% |
2009 | 1% | 0% |
2008 | 1% | 0% |
2007 | 1% | 0% |
2006 | 1% | 0% |
2005 | 1% | +1% |
2004 | 0% | 0% |
2003 | 0% | 0% |
2002 | 0% | 0% |
2001 | 0% | 0% |
2000 | 0% |